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Linkage of body mass index (BMI) to a broad region of chromosome 7q22-35 has been reported in multiple studies.
We previously published a multipoint LOD score of 4.9 at D7S1804 for BMI from the National Heart, Lung, and
Blood Institute Family Heart Study. Leptin (LEP), the human homolog of the mouse obesity (ob) gene, is positioned
near the linkage peak and is the most prominent candidate gene in this region. Interest in LEP as a susceptibility
gene for human obesity has led to numerous linkage and association studies, but the results of these studies are
still controversial. In the present study, we employed family-based tests of association with both a quantitative
measure of BMI adjusted for age and sex and a dichotomously deﬁned obesity trait. We genotyped 29 single-
nucleotide polymorphisms (SNPs) spanning 240 kb around the LEP gene in the 82 extended pedigrees with the
strongest evidence for linkage. When the programs TRANSMIT and FBAT were used, a number of SNPs showed
association in men but not women, for both the quantitative and qualitative trait deﬁnitions ( ). Five SNPsP ! .05
(H1328084, H1328083, H1328082, H1328081, and H1328080) positioned 2 kb beyond the previously deﬁned
promoter region showed strong association in single-marker and multiple-marker haplotype analysis. This ﬁve-
marker haplotype (frequency 49% in this sample) is overtransmitted to obese offspring ( ). All ﬁve ofPp .00005
these SNPs are predicted to modify transcription-factor binding sites. This may indicate new functional variants
in an extended promoter region of LEP.
Introduction
In Western societies, the prevalence of obesity has
been increasing steadily in recent years. Obesity (MIM
601665) is strongly associated with increased risk for
diabetes, lipid disorders, hypertension, and coronary
heart disease (CHD). A genetic component in the eti-
ology of BMI has been clearly demonstrated by epide-
miological and genetic linkage studies (Borecki et al.
1998; Bouchard et al. 1998). Although many candidate
genes have been proposed and numerous genetic studies
performed, the resolution of the genetic factors under-
lying the susceptibility to obesity is far from complete
(Chagnon et al. 2003).
Recently, we reported a genomewide linkage scan for
BMI in the National Heart, Lung, and Blood Institute
(NHLBI) Family Heart Study (FHS) (Feitosa et al.
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2002). A LOD score of 4.9 was found at D7S1804
(7q32.3) for age- and sex-adjusted measures of BMI.
Leptin (LEP) is positioned close to the center of this
linkage peak and is the most prominent candidate gene
in the region because of its central role in an adiposity-
sensing pathway and its physiological effects on energy
balance. The linkage ﬁnding at 7q22-36 has been con-
sistently replicated by numerous studies of independent
samples and supported by strong evidence of linkage in
a meta-analysis of ﬁve published studies (Allison and
Heo 1998; Li et al. 2003; Platte et al. 2003). The can-
didate region is large, extending over the 55 Mb be-
tween D7S618 and D7S3070. The positive linkage ﬁnd-
ings appear to be dispersed across three subregions.
The ﬁrst region is ﬂanked by markers D7S1804 and
D7S3070 at 7q32.3-q36 and is 10–15 cM downstream
of LEP. The second region is near D7S2459/D7S523 at
7q22-31.1 and is 20 cM upstream of LEP. The third
region is at 7q31.3, at the LEP gene. It is not clear
whether these studies point to one or more than one
gene contributing to obesity risk.
Since the identiﬁcation of the LEP gene at 7q31.3 as
the human homolog to the mouse obesity (ob) gene
(Zhang et al. 1994), sequence variation in LEP has been
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studied extensively. Although mutations in the LEP
gene are known to cause rare obesity syndromes (Mon-
tague et al. 1997a; Strobel et al. 1998) and have been
responsible for obesity in several animal models (Zhang
et al. 1994; Moon and Friedman 1997; Friedman and
Halaas 1998), variation within the coding region of
LEP is exceedingly rare in the general population (Con-
sidine et al. 1995; Maffei et al. 1996; Carlsson et al.
1997). The interest in LEP as a susceptibility gene for
human obesity has also led to the identiﬁcation of sev-
eral common polymorphisms in the 5′ regulatory re-
gion—G2548A, A19G, and C1887T—that show as-
sociation with lower LEP levels or obesity in several
studies (Hager et al. 1998; Mammes et al. 1998, 2000;
Li et al. 1999; Le Stunff et al. 2000). Nevertheless, the
results from these studies are still controversial, and the
relationship between LEP sequence variation and hu-
man body weight remains uncertain (Shigemoto et al.
1997; Lucantoni et al. 2000). In the present study, we
describe the results of family-based association analysis
of 29 SNPs spanning 240 kb across the LEP region,
including the previously published SNPs and recently
detected variants. Using linkage disequilibrium (LD)
mapping and haplotype analysis, we sought to establish
the position of the functionally signiﬁcant variant(s).
Subjects and Methods
Subjects and Phenotype
The FHS is a multicenter, population-based study of
factors inﬂuencing risk for CHD. A detailed description
of the FHS has been published elsewhere (Family Heart
Study Web site). We selected a primary genotyping panel
with 548 DNAs derived from the 82 white families with
the highest pedigree-speciﬁc LOD scores from our pre-
vious linkage study (Feitosa et al. 2002). The multipoint
LOD score for these 82 families was 17.09 at 136.95
cM (Genetic Map Index Web site, Center for Medical
Genetics).
BMI was calculated as weight (in kg) divided by the
square of height (in meters). Regression models were
used to adjust for sex, age, and center, as reported else-
where (Feitosa et al. 2002). We also deﬁned a dichot-
omous phenotype (denoted as “OB”) based on the ad-
justed BMI residual (BMI-R). A residual cutoff of 0.6
was used to deﬁne affected individuals. It is notable that
the residual of 0.6 corresponds approximately to a raw
BMI score of 30, which is an accepted clinical desig-
nation for obesity. The dichotomous phenotype (OB)
was coded as affected for those with a BMI-R 0.6, as
unaffected for those with a BMI-R 0 (BMI ∼27.5),
and as ambiguous or unknown if 0 ! BMI-R ! 0.6. Of
the 82 pedigrees selected on the basis of family-speciﬁc
LOD scores, 69 contained at least one individual who
was classiﬁed as affected. The 69 pedigrees contained
186 persons with a BMI-R 10.6 (185 DNAs available),
196 persons with a BMI-R !0 (195 DNAs available),
and 88 persons with a BMI-R between 0 and 0.6 (84
DNAs available). Most persons in the ambiguous group
are founders without DNA. Nonparametric linkage
(NPL) analysis was performed in the 48 families with
at least two individuals classiﬁed as OB, and an NPL
score of 5.16 at 136.95 cM was observed.
Genotyping
Genomic DNA was prepared from whole blood by
using the Puregene system (Gentra Systems) and was
puriﬁed using QIAEX II kits (Qiagen). All of the samples
were quantiﬁed using the PicoGreen DNAquantiﬁcation
method (Ahn et al. 1996) and were diluted to 2.5 ng/ml
before making 96-well PCR source plates.
Five SNPs were selected fromAssays-on-Demand SNP
Genotyping Products, which are validated against ge-
nomic DNAs from four different populations and each
of which has a corresponding allele frequency of at
least 10% in whites. Four SNPs—G2548A, C1887T,
G1387A, and A19G—were selected on the basis of pre-
vious publications of association studies involving LEP
and BMI (Mammes et al. 1998; Li et al. 1999; Le Stunff
et al. 2000). An additional 20 SNPs retrieved from the
human SNP database in the Celera Discovery System
(Celera Discovery SystemWeb site) were also genotyped.
Twenty of these 29 SNPs are in the 22-kb LEP region.
An additional ﬁve SNPs are from the intergenic 5′ region,
two are in the P100 gene 5′ upstream from LEP, and
two are from the 3′ region distal to LEP in an unknown
gene, FLJ10377.
SNPs were genotyped using the TaqMan technology
(Holland et al. 1991; Livak et al. 1995) implemented
on an ABI PRISM 7900HT Sequence Detection System
(Applied Biosystems). PCR was performed using Taq-
Man Universal Master Mix (Applied Biosystems), 5 ng
DNA, 900 nM of each primer, and 200 nM of each
probe in a 5-ml reaction.
Bioinformatic Analysis
Transcription-factor binding sites (TFBS)were queried
for the 50-bp sequence surrounding each 5′ candidate
SNP by comparing the alternative sequence of the two
SNP alleles with the TRANSFAC database by use of
BLAST (Wingender et al. 2000).
Statistical Analysis of Association
The genotypes were checked for Mendelian inheri-
tance errors and Hardy-Weinberg equilibrium in an in-
tegrated database. MERLIN (Abecasis et al. 2002) was
used for detection of apparent double recombinants in
the data and to calculate NPL scores based on OB. Ver-
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Table 1
Characteristics of Study Subjects Genotyped in the 69 Pedigrees
CHARACTERISTIC
OBSERVATION IN
Male Subjects
( )Np 225
Female Subjects
( )Np 245
Mean  SD BMI:
Total sample 29.2  5.1 30.5  7.6
Affected 34.8  4.5 ( )np 76 37.4  5.3 ( )np 110
Unaffected 25.2  2.0 ( )np 97 23.5  2.6 (np 99)
Ambiguous 28.6  1.2 ( )np 52 28.6  2.2 (np 36)
Mean  SD age (in years) 51.5  14.3 52.6  13.1
% of sample from study center:
NC 17.3 12.5
MN 15.0 15.8
MA 19.5 23.1
UT 48.2 48.6
sion 2.5 of the program TRANSMIT (Clayton 1999;
Clayton and Jones 1999) was used to perform the trans-
mission/disequilibrium test (TDT) of association with
OB on single SNPs and multiple-marker haplotypes. P
values for all TDT analyses performed with TRANSMIT
were empirically derived from 100,000 bootstrap rep-
licates. To protect against misleading results due to rare
alleles or haplotypes, the command-line switches (i.e.,
ﬂags) “-agg3” and “-c3” were used to aggregate all al-
leles or haplotypes with frequencies !0.03 before hap-
lotype construction. To test for association in the pres-
ence of linkage, the switches “-1” and “-nomf” were
used to select one trio from each pedigree, to minimize
the dependency on family structure and to maximize the
association signal relative to the linkage signal.
The software package FBAT v1.4 (Horvath et al.
2001) was used to perform the family-based association
tests for the quantitative trait BMI-R in the 69 pedigrees
that included at least one member who was classiﬁed as
affected. The null hypothesis of linkage but no associ-
ation was tested using the -e ﬂag, which computes the
test statistic through use of the empirical variance, be-
cause the sample contains multiple nuclear families in
some pedigrees and multiple affected individuals in these
nuclear families, and the markers are in an area of
known linkage. Multiallelic tests were performed using
an additive genetic model.
Since the markers are tightly linked, results for indi-
vidual SNPs may be highly correlated; thus, a simple
Bonferroni correction is unduly conservative, and we
report the empirical P values as described above. We
used the Benjamini-corrected false-discovery rate (FDR)
to control for multiple hypothesis testing (Benjamini and
Hochberg 1995). The FDR is the expected proportion
of true null hypotheses rejected out of the total number
of null hypotheses rejected. Multiple comparison pro-
cedures controlling the FDR are more powerful than the
commonly used multiple comparison procedures based
on the familywise error rate. After adjustment for mul-
tiple testing and with an FDR level of 0.05, the cutoff
for signiﬁcant association is for analyses of “allPp .01
individuals,” for analyses of “all males,”Pp .033
for analyses of “one trio per pedigree withPp .026
affected male offspring” via a TDT, and inPp .031
FBAT analysis of the families with affected male
offspring.
LD block structure was examined by the program
Haploview (Haploview Web site, Whitehead Institute).
The D′ for all pairs of SNPs was calculated and the
haplotype blocks estimated using the conﬁdence-interval
method (Gabriel et al. 2002). SNPs with low rare-allele
frequencies may inﬂate estimates of D′, and the use of
conﬁdence-bound estimates for D′ reduces this bias. The
default settings were used in these analyses, which in-
voke a one-sided upper 95% conﬁdence bound of
and a lower bound of 10.7 to deﬁne SNP pairs′D 1 0.98
in strong LD. A block is identiﬁed when at least 95%
of SNP pairs in a region meet these criteria for strong
LD. Haplotypes were reconstructed and their frequen-
cies estimated using an accelerated expectation-maxi-
mization (EM) algorithm similar to the partition/ligation
method (Qin et al. 2002) implemented in Haploview.
Results
Characteristics of the study sample are presented in table
1. The unadjusted mean BMI in men and women was
signiﬁcantly different, as assessed by a t test ( ).Pp .04
This difference in mean BMI occurred in both the af-
fected ( ) and unaffected ( ) groups,Pp .0008 P ! .0001
where women had a higher and lower mean BMI,
respectively.
Table 2 shows the map locations and marker char-
acteristics for the 29 SNPs in and around LEP that
were genotyped. Although 4 SNPs—G2548A, A19G,
C1887T, and G1387A—have been previously reported,
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Table 2
Markers and Map Locations
Marker
Number Marker Gene SNP Frequencya
Celera
Location
(bp)
NCBI
Location
(bp)
Intermarker
Intervalb
(bp)
SNP
Type
dbSNP rs
Number
D7S3061 NA 118093192 122844090 … … …
1 C1331361 P100 T/C .348 122524910 127275987 4,431,897 Exon rs322825
2 C1331345 P100 G/A .190 122543069 127294146 18,159 Intron rs6953698
3 C618722 A/G .456 122559253 127310271 16,125 Intergenic rs322785
4 C618685 G/C .272 122592487 127343162 32,891 Intergenic rs53125
5 H1331258 A/G .351 122650302 127400977 57,815 Intergenic rs11772985
6 H1331250 G/A .160 122660615 127411290 10,313 Intergenic rs6947095
7 H1328090 C/A .389 122669402 127420076 8,786 Intergenic rs791601
8 C1328085 LEP T/G .340 122680314 127430988 10,912 5′ ﬂank/TFBS rs10249476
9 H1328084 LEP G/A .411 122680501 127431175 187 5′ ﬂank/TFBS rs1349419
10 H1328083 LEP G/A .495 122681032 127431706 531 5′ ﬂank/TFBS NA
11 H1328082 LEP C/A .345 122681386 127432060 354 5′ ﬂank/TFBS rs12535708
12 H1328081 LEP C/T .404 122681555 127432229 169 5′ ﬂank/TFBS rs11770725
13 H1328080 LEP C/A .341 122681623 127432297 68 5′ ﬂank rs12535747
14 G2548A LEP G/A .495 122682071 127432745 448 Promoter rs7799039
15 H6501175 LEP A/G .446 122682636 127433310 565 Promoter rs6467166
16 H2944325 LEP G/A .493 122682656 127433330 20 Promoter rs12536535
17 C1887T LEP C/T .092 122682732 127433406 76 Promoter NA
18 G1387A LEP A/G .446 122683231 127433905 499 Promoter NA
19 A19G LEP G/A .342 122684637 127435311 1,406 Exon1/5′ UTR rs2167270
20 H1328078 LEP T/C .407 122685139 127435813 502 Intron 1 rs2278815
21 H1432616 LEP G/T .423 122690353 127441030 5,217 Intron 1 NA
22 H1432615 LEP G/A .426 122690424 127441101 71 Intron 1 NA
23 H1328076 LEP A/T .476 122691974 127442651 1,550 Intron 1 rs10244329
24 H3001671 LEP A/G .477 122693347 127444024 1,373 Intron 1 rs11763517
25 H1328074 LEP G/A .356 122694372 127445049 1,025 Intron 1 rs11760956
26 C1328073 LEP G/A .363 122694725 127445402 353 Intron 1 rs10954173
27 C3001667 LEP A/G .424 122702403 127453091 7,689 Intron 2 rs2060715
28 C1574222 FLJ10377 G/A .353 122753843 127504687 51,596 3′ UTR rs12850
29 C1328040 FLJ10377 C/G .306 122768526 127519371 14,684 Intron rs10279576
D7S1804 NA 127031883 131246812 3,727,441 … …
a Allele frequency for the second allele is shown.
b Marker intervals are calculated on the basis of NCBI locations (National Center for Biotechnology Information Web site).
the remaining 25 have not been studied for LEP as-
sociation. The markers are presented according to their
physical location, with D7S3061 centromeric. SNPs
tested in LEP are intronic except for A19G, which is
in the ﬁrst exon, 5′ UTR region of the LEP gene. The
rare-allele frequency for those SNPs is between 16%
and 50% except for C1887T, which has a rare-allele
frequency of 9%. Strong LD extends from the 5′ region
to the ﬁrst intron of LEP but does not extend to SNPs
in the genes distal and proximal to LEP (ﬁg. 1).
Seven LD blocks are identiﬁed across the 240-kb re-
gion (see ﬁg. 1). We explored the haplotype diversity in
this region through use of Haploview. Figure 2 depicts
the values for D′ between the multi-SNP blocks deﬁned
in ﬁgure 1. Haploview identiﬁed tag SNPs for parsi-
monious haplotypes for each block (Johnson et al. 2001;
Patil et al. 2001).
In each analysis, the TDT was performed for all in-
dividuals as well as for male and female family members
separately. The SNPs that remain signiﬁcant after Ben-
jamini correction are indicated with an asterisk (*). In
the TDT conducted on the entire sample (the “All” col-
umn in table 3), 5 of the 20 LEP SNPs showed signif-
icant association with OB ( ) after Benjamini cor-P ! .05
rection, but none of these markers remained signiﬁcant
when a “one trio only” TDT analysis was used. When
sex-speciﬁc analyses were conducted, the association
was seen almost exclusively among men. Overall,
among all men, 16 SNPs in the “all individual” analysis
( ) and 13 in the “one trio” analysis ( )P ! .013 P ! .038
showed signiﬁcant association with OB. Although the
level of signiﬁcance was slightly lower in the FBAT anal-
ysis compared with the TRANSMIT results, the same
pattern of association was also observed when the quan-
titative trait BMI-R was used. Seventeen of 20 SNPs in
LEP showed signiﬁcant association ( with Ben-P ! .031
jamini correction). In both analyses, SNPs with strong
association are seen in men and are clustered between
markers H1331250 and H1328076. The 117 male off-
spring (64 affected, 36 unaffected, and 17 ambiguous)
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Figure 1 LD block structure around LEP. Haplotype block structure, as depicted by Haploview, is shown. The ﬁve-color scheme (white
to red) represents the increasing strength of LD. Values for D′ (#100) are shown, but those boxes with are shaded in bright red and′D p 1
are empty. Cells with are shades of pink or red. Blue represents but with a low conﬁdence estimate for D′.′ ′D ! 1 D p 1
are very similar to the sample of all 225 male subjects
described in table 1, except that they are slightly heavier
(mean BMI 31.1 vs. 29.2 in the total sample) and
younger (mean age 45.8 years vs. 51.5 years in the total
sample).
We sought to establish the boundary of the signiﬁcant
association, which extended from 25 kb upstream of
LEP to its ﬁrst intron, by applying the TDT to single
markers. We conﬁrmed the previously published asso-
ciation with BMI at markers A19G and G2548A (Hager
et al. 1998; Mammes et al. 1998, 2000; Li et al. 1999);
G2548A showed a strong association with OB in both
the “all individuals” ( ) and the “one trioPp .00007
per pedigree” ( ) analyses, as well as withPp .00002
BMI-R ( ) in the FBAT analysis. All of thesePp .003
associations were found solely in men. A19G showed
a strong association in the TDT conducted on the entire
sample ( ) but only a moderate association forPp .004
the “one trio per pedigree” analysis in men ( ).Pp .017
We also analyzed two-, three-, four-, and ﬁve-
marker haplotypes for the 29 SNPs, and ﬁgure 3
shows the results for the three-marker haplotypes
tested. The “global” P value represents the overall
signiﬁcance when the observed versus expected trans-
missions of all of the haplotypes are considered to-
gether. Although multiple LEP haplotypes showed as-
sociation after correction for multiple testing, only
two common haplotypes show signiﬁcance globally:
H1328083-H1328082-H1328081, with global Pp
, and H1328082-H1328081-H1328080, with.006
global . The haplotype with the strongestPp .009
association is a composition of allele A of H1328083,
allele C of H1328082, and allele C of H1328081
(frequency 49%), overtransmitted from parents to
their affected offspring ( ).Pp .00001
Results of two-marker haplotype analysis resembled
those for single-marker analysis (data not shown), and
the four-marker and ﬁve-marker haplotype results were
similar to the ﬁndings for the reported three-marker
haplotypes. Among the four-marker haplotypes, two
showed signiﬁcant association globally: H1328084-
H1328083-H1328082-H1328081 and H1328083-
H1328082-H1328081-H1328080.
One common ﬁve-SNP haplotype, representing al-
leles G, A, C, C, and C from SNPs H1328084,
H1328083, H1328082, H1328081, and H1328080,
respectively, was found to be overtransmitted to af-
fected offspring ( ) and spans a region ∼2Pp .00005
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Figure 2 Haplotype structure and diversity. Haplotype blocks and their frequencies were estimated using an accelerated EM algorithm
implemented in Haploview. SNP numbers corresponding to ﬁgure 1 are listed above each column of alleles, and “” denotes the tag SNPs that
designate a parsimonious haplotype for each block. Recombination rates from one block to the next are deﬁned by a multiallelic value of D′.
Haplotypes in adjacent blocks are connected by a thick line if they occur together with a frequency 110% and by a thin line if they occur
together with a frequency 11%. For each SNP, “1” represents the common allele, and “2” represents the rare allele.
kb up from the previously deﬁned promoter region
(Gong et al. 1996). This ﬁve-marker haplotype can be
simpliﬁed to three tag SNPs—H1328081 (which is
equivalent to H1328084), H1328082 (which is equiv-
alent to C1328085 and H1328080), and H1328083—
but it is not clear which combination of three is most
informative. Bioinformatic analysis revealed that all
ﬁve of these SNPs are predicted to modify TFBS (see
ﬁg. 4). Although G2548A shows a strong individual
SNP association to OB (table 3), it is in strong LD
with H1328083 ( ), and, thus, G2548A may2r p 0.97
not add signiﬁcantly to the information provided by
that SNP to the common ﬁve-SNP haplotype.
Discussion
To assess the role of LEP in association with BMI, we
performed a family-based study for both a dichotomous
obesity characterization (OB) and a quantitative BMI
residual measurement (BMI-R). A number of recently
identiﬁed SNPs showed strong association with both of
these measures in the 82 pedigrees with the strongest
evidence for linkage ( ). The association signalsP ! .01
came exclusively from men, and a sex effect of this mag-
nitude in LEP has not been previously reported. The
boundary of signiﬁcant association extended from 25 kb
upstream of LEP to its ﬁrst intron. We identiﬁed a com-
mon risk haplotype with frequency of 49%, which is
overtransmitted to obese offspring ( ) andPp .00005
positioned 2 kb up from the previously deﬁned LEP
promoter. The ﬁve SNPs (H1328084-H1328083-
H1328082-H1328081-H1328080) in this high-risk
haplotype are predicted to modify TFBS, and, thus, any
one of them may be functionally implicated for modi-
fying the transcription of LEP. Because the SNPs are in
very high LD and span a very small region (∼1.2 kb),
it is difﬁcult to discern which SNP(s) is most likely im-
plicated in LEP transcription. Future functional analyses
using various combinations of these variants may help
to conﬁrm these ﬁndings and provide insight into the
function of each variant.
In addition to the ﬁve SNPs mentioned above, we
also conﬁrmed the previously reported (Mammes et al.
1998, 2000; Li et al. 1999; Le Stunff et al. 2000) strong
association between G2548A and BMI ( ) inPp .00002
a single-marker TDT, but the association with this
marker is not detected in any multimarker haplotype
analysis. Since this SNP is neither at a conserved region
among human, mouse, and rat, nor at a predicted TFBS
(Li et al. 1999), its functional importance is speculative.
Nevertheless, we cannot rule out the possibility that
more than one functional polymorphism in LEP affects
variation in BMI. The ﬁnding that G2548A shows
strong association in single-marker analysis but does not
show association in combination with other SNPs, such
as those found in the ﬁve-SNP haplotype, may indicate
that it is associated with an independent functional
polymorphism.
The previously reported A19G SNP, in the 5′ UTR of
the ﬁrst exon of LEP (Hager et al. 1998; Li et al. 1999),
shows only a modest association with OB in a stringent
TDT using only one trio per pedigree ( in men)Pp .017
and a similar modest association with BMI-R in FBAT
analysis. The ﬁnding that only men show LEP associ-
ation with BMI may explain the low frequency of rep-
lication for the association of BMI with LEP. Further-
more, the modest effect occasionally observed for the
A19G polymorphism may be attributable to strong LD
between this SNP and SNPs in the haplotype ( 2r p
for A19G and H1328084; for20.984 r p 0.681
H1328083), which appear to have a much stronger
association with obesity.
The characteristics of promoter region for LEP have
been reported elsewhere (Gong et al. 1996). Of note is
that all ﬁve SNPs in the risk haplotype are in a 2-kb
region 5′ to the reported promoter that may represent
an enlarged promoter region for LEP. All ﬁve SNPs in
this haplotype modify predicted TFBS (see ﬁg. 4). For
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Table 3
TDT of Association to OB as a Qualitative Trait in TRANSMIT, and BMI-R as a Quantitative Trait in FBAT
SNP IDa
TRANSMIT P VALUEb
All Individuals One Trio per Pedigree BMI-R (-e) FBAT P VALUE
Allc
( )np 470
Femaled
( )np 423
Malee
( )np 315
Allf
( )np 198
Femaleg
( )np 165
Maleh
( )np 114
Allc
( )np 470
Femaled
( )np 423
Malee
( )np 315
C1361 .261 .692 .220 .018 .261 .138 .173 .649 .093
C1345 .974 .806 .821 .976 .704 .889 .558 .614 .634
C8722 .346 .775 .255 .245 .682 .016* .577 .718 .100
C8685 .027 .026 .420 .493 .092 .703 .147 .104 .550
H1258 .400 .948 .093 .463 .318 .391 .426 .424 .730
H1250 .023 .625 .0003* .288 .887 .039 .238 .626 .022*
H8090 .136 .259 .345 .050 .183 .532 .258 .648 .138
C8085 .005* .254 .002* .082 .650 .0002* .095 .893 .009*
H8084 .017 .265 .008* .179 .958 .005* .077 .736 .007*
H8083 .075 .947 .001* .618 .836 .007* .231 .340 .003*
H8082 .001* .173 .0004* .107 .803 .011* .059 .967 .005*
H8081 .022 .388 .005* .173 .789 .009* .147 .917 .010*
H8080 .004* .240 .001* .201 .671 .034 .113 .708 .008*
2548A .114 .714 .00007* .714 .311 .00002* .246 .325 .003*
H1175 .036 .665 .0008* .074 .663 .0001* .339 .317 .008*
H4325 .132 .990 .007* .302 .838 .048 .551 .109 .007*
1887T .344 .121 .370 .862 .417 .0002* .327 .160 .361
1387A .064 .975 .0002* .782 .679 .0003* .741 .152 .028*
A19G .002* .113 .004* .126 .769 .017* .049 .631 .010*
H8078 .006* .307 .001* .133 .796 .00002* .073 .888 .003*
H2616 .057 .560 .011* .028 .774 .134 .299 .586 .014*
H2615 .035 .442 .006* .009 .385 .004* .138 .955 .007*
H8076 .175 .879 .005* .150 .207 .015* .751 .091 .014*
H1671 .327 .819 .031 .363 .576 .052 .486 .241 .013*
H8074 .055 .418 .031 .240 .423 .061 .232 .777 .034
C8073 .072 .350 .065 .475 .855 .384 .218 .975 .041
C1667 .936 .304 .113 .599 .081 .107 .682 .069 .067
C4222 .072 .021 .613 .028 .249 .556 .248 .071 .970
C8040 .104 .020 .717 .057 .498 .988 .158 .067 .852
a Celera SNP IDs are abbreviated to the ﬁnal four digits.
b P values are generated by simulation of 100,000 bootstrap sampling. P values !.05 are in boldface italic, and P values signiﬁcant after
FDR adjustment are indicated by an asterisk (*).
c 470 individuals in 69 pedigrees.
d 423 individuals in 62 pedigrees with female affected offspring.
e 315 individuals in 44 pedigrees with male affected offspring.
f 198 individuals in 66 trios with affected offspring.
g 165 individuals in 55 trios with affected female offspring.
h 114 individuals in 38 trios with affected male offspring.
example, the modiﬁcation of the A allele to a C allele
of SNP H1328082 results in the loss of a GATA-1 bind-
ing site. Recently, functional variation for complex phe-
notypes has been detected for changes other than those
altering the structure of the protein encoded by the re-
sponsible gene (Toma et al. 2002). Much of the genetic
component of human phenotypic diversity, including
susceptibility to disease, is hypothesized to be the result
of cis-acting inﬂuences on gene expression. If this hy-
pothesis is correct, it implies that cis-acting regulatory
variation may be a common phenomenon. It is also
supported by some of the recent successes in the ﬁelds
of diabetes (Horikawa et al. 2000), inﬂammatory bowel
disease (Rioux et al. 2001), and schizophrenia (Ste-
fansson et al. 2002; Straub et al. 2002), in which no
obvious pathogenic coding changes have yet been iden-
tiﬁed. These observations have re-emphasized the pos-
sibility that inherited variation in gene expression may
play an important role in susceptibility to complex traits
such as obesity (Lander 1996; Peltonen and McKusick
2001). However, our current knowledge of regulatory
elements in the human genome is far from comprehen-
sive, and, beyond their coding sequences, most genes
are not well annotated.
We genotyped the two previously reported LEP mu-
tations, Met110Val and Arg105Trp (Karvonen et al.
1998; Strobel et al. 1998), and neither of them was
present in our FHS samples, conﬁrming that these mu-
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Figure 3 Haplotype analyses using one trio in each pedigree for a three-marker sliding window. Below each triad is the P value for that
haplotype, the haplotype frequency, the direction of the transmitted haplotype (either overtransmitted [“O”] or undertransmitted [“U”]), and
the global P value (median value of 20 runs), derived by evaluation of the transmissions of all haplotypes simultaneously. SNPs within the LEP
gene are in boldface and are offset, and the approximate location within the LEP gene is shown below the haplotype frequencies. 1p common
allele; 2 p rare allele; InterDis p marker-to-marker distance (in bp); na p no haplotype resulted in ; ns p not signiﬁcant; Global-P ! .05
1nomf (P value) p global P value in the “one trio per pedigree” analysis. Celera SNP IDs are abbreviated to the ﬁnal four digits. P values
signiﬁcant after FDR adjustment are indicated with an asterisk (*).
tations are exceedingly rare in the general population.
Although the high-risk haplotype we identiﬁed is very
common in FHS families showing linkage to the 7q22-
35 region (49%), it is less clear how common this hap-
lotype may be in the general population or in other
genetic studies of obesity.
Sex-speciﬁc analyses show that the signiﬁcant asso-
ciation for LEP was seen almost exclusively among men
in this sample. This ﬁnding lends support to an unex-
pected sex effect between the LEP gene and BMI. Only
two studies have included sex-stratiﬁed analyses for
LEP and BMI or obesity (Mammes et al. 1998, 2000).
These studies found that the G allele of SNP G2548A
was more frequent in overweight subjects of both sexes
( ). However, only male carriers of this allele hadP ! .01
lower LEP concentrations after adjusting for fat mass
( ). The T allele of C1887T was associated withPp .05
a decrease in LEP levels in response to a restrictive diet
( ) but was not associated with BMI or LEPPp .005
concentration. However, because of the small number
of T-allele carriers, one cannot rule out the possibility
that this decrease represents random variability. Nev-
ertheless, these results are consistent with our ﬁnding
that the common G allele of G2548A is overtransmitted
in the OB offspring. A sex-speciﬁc genetic component
in BMI has been reported in Norwegian twins (Harris
et al. 1995) and Mexican Americans (Comuzzie et al.
1995), as well as in whites in the Framingham Study
(Atwood et al. 2003). Sex-speciﬁc differences in human
LEP mRNA expression have been implicated by pre-
vious studies (Montague et al. 1997b). The HERITAGE
family study demonstrated that the association between
the LEP receptor gene and adiposity was found only in
white males (Chagnon et al. 2000). We may speculate
that a candidate for the connection between LEP and
sex-speciﬁc phenotypic differences is testosterone,
which is down-regulated by leptin (Tena-Sempere et al.
2001). The ﬁnding that the effect of LEP is mainly in
men, while linkage to the region is seen in both male
and female subgroups in our study, suggests that there
may be other important BMI-related genes in the 7q22-
35 region that are worthy of additional investigation.
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Figure 4 Genomic view of the LEP 5′ region, its polymorphisms, and the best ﬁve-marker haplotype. A, Genomic view of LEP mRNA
and SNPs surrounding LEP (UCSC Genome Browser Web site). B, Polymorphisms at the 5′ region of LEP, with single-marker P values from
TRANSMIT analysis and their respective putative TFBS, with the polymorphic site highlighted in red. No TFBS changes were found for G2548A
and G1387A. na p no TFBS site identiﬁed for a speciﬁc short sequence.
In summary, the strong association of a number of
common variants and haplotypes in the 5′ region ofLEP
with both a quantitative measure of BMI adjusted for
age and sex and a dichotomously deﬁned obesity trait
in the present study suggest that common LEP sequence
variants are associated with obesity in the general pop-
ulation. The common risk haplotype identiﬁed from this
study may be clinically useful for identifying a subgroup
of people who may have a LEP deﬁciency derived from
altered regulatory elements and may predispose this
subgroup to obesity. It will be valuable to replicate these
ﬁndings in other family sets showing linkage to this
region and to test for association to BMI in independent
studies.
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